In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to Monopar Therapeutics Inc (MNPR –
Tag: NASDAQ:MNPR
Monopar Therapeutics Inc (MNPR) Receives a Buy from Maxim Group
Maxim Group analyst Jason McCarthy assigned a Buy rating to Monopar Therapeutics Inc (MNPR – Research Report) yesterday and set
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Monopar Therapeutics Inc (NASDAQ: MNPR) and Selecta Biosciences (NASDAQ: SELB)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Monopar Therapeutics Inc
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (NASDAQ: MNPR) and Infinity Pharma (NASDAQ: INFI)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monopar Therapeutics
Maxim Group Thinks Monopar Therapeutics Inc’s Stock is Going to Recover
In a report released yesterday, Jason McCarthy from Maxim Group reiterated a Buy rating on Monopar Therapeutics Inc (MNPR –
Monopar Therapeutics Inc (MNPR) Receives a Buy from Brookline Capital Markets
In a report released today, Kumaraguru Raja from Brookline Capital Markets maintained a Buy rating on Monopar Therapeutics Inc (MNPR
Monopar Therapeutics Inc (MNPR) Gets a Buy Rating from JonesTrading
In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Monopar Therapeutics Inc (MNPR – Research